USPTO serial 79462708
POSLUMA XACT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with POSLUMA XACT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; positron emission tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in positron emission tomography (PET) imaging for laboratory and research use; reagents for use in positron emission tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use. | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; positron emission tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |